BEIJING, June 27 CMED-Form-20-F
BEIJING, June 27 /Xinhua-PRNewswire-FirstCall/ -- China Medical
Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based
medical device company that develops, manufactures and markets advanced
in-vitro diagnostic products and high intensity focused ultrasound tumor
therapy systems, today announced the filing of its annual report on Form 20-F
for the fiscal year ended March 31, 2008 with the Securities and Exchange
Commission. The annual report, which contains the Company's audited
consolidated financial statements, can be accessed on the Company's investor
relations website at http://ir.chinameditech.com .
Shareholders can receive a hard copy of the annual report free of charge
by sending a request to IR@chinameditech.com.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company
that develops, manufactures and markets advanced in-vitro diagnostic products
using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ
Hybridization (FISH) technology, to detect and monitor various diseases and
disorders, and products using High Intensity Focused Ultrasound (HIFU) for the
treatment of solid cancers and benign tumors. For more information, please
visit http://www.chinameditech.com .
For more information, please contact:
Winnie Yam
Tel: +86-10-6530-8833
Email: IR@chinameditech.com
SOURCE China Medical Technologies, Inc.
